Cramer's using his years of experience in day trading to explain the perils involved

Lightning Round: Be careful with Under Armour because Nike is coming back with a vengeance

Mad Money - 12/20/24 | Audio Only

Cramer is breaking down the signs to identify when to spot an exquisite market moment

Final Trade: XLV, DEO, OIH & BTC

The ‘Fast Money’ traders give their charts of the year

The house has enough votes to pass stopgap funding bill to avert government shutdown

BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

Stocks jump after Chicago Fed’s Goolsbee comments on rates

SES CEO on key role in space telecom, expanding connectivity and successful space launch

Mercer's Olaolu Aganga gives Mercer's 2025 economic outlook

Guideline CEO on helping small businesses navigate 401(k)'s with AI

I hope congress can get its act together, says U.S. Commerce Secretary Gina Raimondo

There's an unusual amount of policy uncertainty now, says Fmr. Fed President Eric Rosengren

A key level on the VIX is waving a green flag for investors, says DataTrek's Nicholas Colas

Signs of a growth slowdown could put stocks under pressure in 2025, says Unlimited CEO Bob Elliott

Jury finds Qualcomm custom CPUs are licensed under ARM deal, reports say

Nike's problem is larger than marketing, says JPMorgan's Matt Boss

This next year is a 'stock-picker's market,' says Hightower Advisors' Michael Farr

Market Navigator: The economy's impact on road & rail

Parameters needed in college athletics transfer portals, says TN State football coach Eddie George

3-Stock Lunch: Alibaba, O'Reilly Auto, & Upstart

CNBC's Tyler Mathisen says goodbye and reflects on his 27 years at the network

Rates drop on easing inflation

Bitcoin falls to $96,000 as volatility hits crypto assets: CNBC Crypto World

James Pethokoukis on Elon Musk's influence in US politics

Why Nike could be poised for a turnaround

Michael Landsberg says he would 'stay away' from small caps

OpenAI announces o3 and o3 mini models

Novo Nordisk: Why the stock of the Danish pharmaceutical giant is plunging